Erratum: SiRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo (Bioscience Reports DOI: 10.1042/BSR20140124);SiRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo

Bioscience Reports

Volumn 35, Issue , 2015, Pages

  Hu, Peng ^a   Chen, Xi ^a   Sun, Jing ^a   Bie, Ping ^a   Zhang, Lei Da ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

NUF2; Pancreatic cancer; RNA interference; Treatment; Tumourigenesis

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1; LENTIVIRUS VECTOR; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN CDC25A; PROTEIN NUF2; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; NUF2 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER PROGNOSIS; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COLONY FORMATION; CONTROLLED STUDY; DRUG TARGETING; EMBRYO; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; MTT ASSAY; NONHUMAN; NUDE MOUSE; PANC 1 CELL LINE; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SW1990 CELL LINE; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; RNAI THERAPEUTICS; TUMOR CELL LINE;

LENTIVIRUS; MUS MUSCULUS;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREAS; PANCREATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNAI THERAPEUTICS;

EID: 84921782012     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR-20140124_EOC     Document Type: Erratum

References (31)

1. Li, D., Xie, K., Wolff, R. and Abbruzzese, J.L. (2004) Pancreatic cancer. Lancet 363, 1049-1057 CrossRef PubMed
2. Siegel, R., Naishadham, D. and Jemal, A. (2013) Cancer statistics, 2013. Cancer J. Clin. 63, 11-30 CrossRef
3. Cress, R.D., Yin, D., Clarke, L., Bold, R. and Holly, E.A. (2006) Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control 17, 403-409 CrossRef PubMed
4. O'Reilly, E.M. and Lowery, M.A. (2012) Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers. Cancer J. 18, 609-613 CrossRef PubMed
5. Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R.H., Eshleman, J.R., Nowak, M.A. et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 CrossRef PubMed
6. Pluchino, K.M., Hall, M.D., Goldsborough, A.S., Callaghan, R. and Gottesman, M.M. (2012) Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist. Updat. 15, 98-105 CrossRef PubMed
7. Dakhel, S., Padilla, L., Adan, J., Masa, M., Martinez, J.M., Roque, L., Coll, T., Hervas, R., Calvis, C., Messeguer, R. et al. (2014) S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer. Oncogenesis 3, e92 CrossRef PubMed
8. Rieder, C.L. and Salmon, E.D. (1998) The vertebrate cell kinetochore and its roles during mitosis. Trends Cell Biol. 8, 310-318 CrossRef PubMed
9. Millband, D.N., Campbell, L. and Hardwick, K.G. (2002) The awesome power of multiple model systems: interpreting the complex nature of spindle checkpoint signaling. Trends Cell Biol. 12, 205-209 CrossRef PubMed
10. Wigge, P.A. and Kilmartin, J.V. (2001) The Ndc80p complex from Saccharomyces cerevisiae contains conserved centromere components and has a function in chromosome segregation. J. Cell Biol. 152, 349-360 CrossRef PubMed
11. Nabetani, A., Koujin, T., Tsutsumi, C., Haraguchi, T. and Hiraoka, Y. (2001) A conserved protein, Nuf2, is implicated in connecting the centromere to the spindle during chromosome segregation: a link between the kinetochore function and the spindle checkpoint. Chromosoma 110, 322-334 CrossRef PubMed
12. DeLuca, J.G., Moree, B., Hickey, J.M., Kilmartin, J.V. and Salmon, E.D. (2002) hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells. J. Cell Biol. 159, 549-555 CrossRef PubMed
13. Shiraishi, T., Terada, N., Zeng, Y., Suyama, T., Luo, J., Trock, B., Kulkarni, P. and Getzenberg, R.H. (2011) Cancer/testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy. J. Transl. Med. 9, 153 CrossRef PubMed
14. Sethi, G., Pathak, H.B., Zhang, H., Zhou, Y., Einarson, M.B., Vathipadiekal, V., Gunewardena, S., Birrer, M.J. and Godwin, A.K. (2012) An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. PLoS ONE 7, e47086 CrossRef PubMed
15. Kaneko, N., Miura, K., Gu, Z., Karasawa, H., Ohnuma, S., Sasaki, H., Tsukamoto, N., Yokoyama, S., Yamamura, A., Nagase, H. et al. (2009) siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis. Biochem. Biophys. Res. Commun. 390, 1235-1240 CrossRef PubMed
16. Gurzov, E.N. and Izquierdo, M. (2006) RNA interference against Hec1 inhibits tumor growth in vivo. Gene Ther. 13, 1-7 CrossRef PubMed
17. Numnum, T.M., Makhija, S., Lu, B., Wang, M., Rivera, A., Stoff-Khalili, M., Alvarez, R.D., Zhu, Z.B. and Curiel, D.T. (2008) Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines. Gynecol. Oncol. 108, 34-41 CrossRef PubMed
18. Hayama, S., Daigo, Y., Kato, T., Ishikawa, N., Yamabuki, T., Miyamoto, M., Ito, T., Tsuchiya, E., Kondo, S. and Nakamura, Y. (2006) Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res. 66, 10339-10348 CrossRef PubMed
19. Kobayashi, Y., Takano, A., Miyagi, Y., Tsuchiya, E., Sonoda, H., Shimizu, T., Okabe, H., Tani, T., Fujiyama, Y. and Daigo, Y. (2014) Cell division cycle-associated protein 1 overexpression is essential for the malignant potential of colorectal cancers. Int. J. Oncol. 44, 69-77 PubMed
20. Wang, D., Sun, S.Q., Yu, Y.H., Wu, W.Z., Yang, S.L. and Tan, J.M. (2014) Suppression of SCIN inhibits human prostate cancer cell proliferation and induces G0/G1 phase arrest. Int. J. Oncol. 44, 161-166 PubMed
21. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408 CrossRef PubMed
22. Charters, G.A., Stones, C.J., Shelling, A.N., Baguley, B.C. and Finlay, G.J. (2011) Centrosomal dysregulation in human metastatic melanoma cell lines. Cancer Genet. 204, 477-485 CrossRef PubMed
23. Cheerambathur, D.K., Gassmann, R., Cook, B., Oegema, K. and Desai, A. (2013) Crosstalk between microtubule attachment complexes ensures accurate chromosome segregation. Science 342, 1239-1242 CrossRef PubMed
24. Menon, V.R., Peterson, E.J., Valerie, K., Farrell, N.P. and Povirk, L.F. (2013) Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest. Biochem. Pharmacol. 86, 1708-1720 CrossRef PubMed
25. Song, Y., Lin, X., Kang, D., Li, X., Zhan, P., Liu, X. and Zhang, Q. (2014) Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate. Eur. J. Med. Chem. 82, 293-307 CrossRef PubMed
26. Aneknan, P., Kukongviriyapan, V., Prawan, A., Kongpetch, S., Sripa, B. and Senggunprai, L. (2014) Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells. Asian Pac. J. Cancer Prev. 15, 5071-5076 CrossRef PubMed
27. Brower, V. (2010) RNA interference advances to early-stage clinical trials. J. Natl. Cancer Inst. 102, 1459-1461 CrossRef PubMed
28. Eifler, A.C. and Thaxton, C.S. (2011) Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study. Methods Mol. Biol. 726, 325-338 CrossRef PubMed
29. Hall, P.A., Levison, D.A., Woods, A.L., Yu, C.C., Kellock, D.B., Watkins, J.A., Barnes, D.M., Gillett, C.E., Camplejohn, R., Dover, R. et al. (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162, 285-294 CrossRef PubMed
30. Bravo, R., Frank, R., Blundell, P.A. and Macdonald-Bravo, H. (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326, 515-517 CrossRef PubMed
31. Wu, G., Qiu, X.L., Zhou, L., Zhu, J., Chamberlin, R., Lau, J., Chen, P.L. and Lee, W.H. (2008) Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal. Cancer Res. 68, 8393-8399 CrossRef PubMed